Hong Kong Mansaibe Biotechnology Limited Company Information

Current Status : Live


Hong Kong Mansaibe Biotechnology Limited's Hong Kong CR Number is 3035333. Incorporation Date is 07-APR-2021. It's Winding up Mode is None. Dissolution date is None. Hong Kong Mansaibe Biotechnology Limited company is of Private company limited by shares Type.
Additional Remarks on the Hong Kong Mansaibe Biotechnology Limited company are None.

Company Data

CRN3035333
Company NameHong Kong Mansaibe Biotechnology Limited
Chinese Name香港曼莎伊貝生物科技有限公司
Active StatusLive
Register of ChargesUnavailable
TypePrivate company limited by shares
See other companies with same Type - Private company limited by shares
Winding Up ModeNone
Date of Incorporation07-APR-2021
See companies with same Incorporation Date - 07-APR-2021
Date of DissolutionNone
RemarksNone
Important NoteNone
Tagsbiotechnology   hong   mansaibe   kong   
Find Similar Companies by these tags.

Company Name History Information :

Effective DatePrevious Name
Hong Kong Mansaibe Biotechnology Limited香港曼莎伊貝生物科技有限公司07-APR-2021

FAQs:

When was Hong Kong Mansaibe Biotechnology Limited incorporated?

Hong Kong Mansaibe Biotechnology Limited was incorporated on 07-APR-2021 in Hongkong.

What is the type of Hong Kong Mansaibe Biotechnology Limited?

Hong Kong Mansaibe Biotechnology Limited is classified as Private company limited by shares.

What is the current status of Hong Kong Mansaibe Biotechnology Limited Company?

The status of Hong Kong Mansaibe Biotechnology Limited is Live.

What is the CR Number of Hong Kong Mansaibe Biotechnology Limited?

The CR Number of Hong Kong Mansaibe Biotechnology Limited is 3035333.

* We are trying our best to keep all the data correct and up-to-date. It should be noted that it is not the primary source of the information on the company Hong Kong Mansaibe Biotechnology Limited. The official registry should always be referred for latest information.

Last Updated on 09-04-2021.

Check other companies added on 09-04-2021

Check out Companies Incorporated on 07-APR-2021: